MRI and prediction of pathologic complete response in the breast and axilla after neoadjuvant chemotherapy for breast cancer
Journal of the American College of Surgeons Sep 20, 2017
Weber JJ, et al. - In the setting where determining extent of residual disease is key for surgical planning after neoadjuvant chemotherapy (NAC), herein researchers assess the reliability of MRI in predicting pathologic complete response (pCR) of the breast primary and axillary nodes following NAC. Observations suggest radiologic complete response by MRI as not predictive of pCR with adequate accuracy to replace pathologic evaluation of the breast tumor and axillary nodes.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries